{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:30:42Z","timestamp":1783402242275,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jaci.2019.12.010","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T17:48:39Z","timestamp":1576691319000},"page":"1157-1164.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-5161","authenticated-orcid":false,"given":"Paul J.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejal","family":"Saglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Erlewyn-Lajeunesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Kansra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Nagakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sejal","family":"Saglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Stiefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.12.010_bib1","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaci.2019.12.010_bib2","doi-asserted-by":"crossref","first-page":"e1001527","DOI":"10.1371\/journal.pmed.1001527","article-title":"Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modeling study","volume":"10","author":"Baguelin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaci.2019.12.010_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2019-20 Influenza Season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaci.2019.12.010_bib5","doi-asserted-by":"crossref","unstructured":"Pebody RG, Whitaker H, Ellis J, Andrews N, Marques DFP, Cottrell S, et\u00a0al. End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018\/19 [published online ahead of print November 1, 2019]. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.071.","DOI":"10.1016\/j.vaccine.2019.10.071"},{"key":"10.1016\/j.jaci.2019.12.010_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.12.010_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.inf.0000109392.96411.4f","article-title":"Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents","volume":"23","author":"Bergen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2019.12.010_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.vaccine.2011.11.104","article-title":"The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2019.12.010_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1750-2659.2011.00243.x","article-title":"An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jaci.2019.12.010_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/INF.0b013e3181660c2e","article-title":"Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial","volume":"27","author":"Gaglani","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2019.12.010_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2019.12.010_bib13","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2011.04.113","article-title":"A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in non-recommended children younger than 5 years","volume":"29","author":"Tennis","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2019.12.010_bib14","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1016\/j.vaccine.2012.02.039","article-title":"A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2019.12.010_bib15","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1016\/j.vaccine.2012.07.031","article-title":"A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season","volume":"30","author":"Tennis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2019.12.010_bib16","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1016\/j.vaccine.2019.05.081","article-title":"Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma","volume":"37","author":"Nordin","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2019.12.010_bib17","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.vaccine.2017.03.082","article-title":"Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines","volume":"35","author":"Ray","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2019.12.010_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02130-2018","article-title":"Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006-2016","volume":"53","author":"Bloom","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2019.12.010_bib19","doi-asserted-by":"crossref","first-page":"h6291","DOI":"10.1136\/bmj.h6291","article-title":"Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study","volume":"351","author":"Turner","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2019.12.010_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2019.12.010_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2011.08.010","article-title":"Test for Respiratory and Asthma Control in Kids (TRACK): clinically meaningful changes in score","volume":"128","author":"Zeiger","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.12.010_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2019.12.010_bib25","doi-asserted-by":"crossref","first-page":"16075","DOI":"10.1038\/npjpcrm.2016.75","article-title":"Measurement characteristics of the childhood Asthma-Control Test and a shortened, child-only version","volume":"26","author":"Bime","year":"2016","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaci.2019.12.010_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.12.010_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.12.010_bib28","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s10096-012-1595-9","article-title":"The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing","volume":"31","author":"Ambrose","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jaci.2019.12.010_bib29","doi-asserted-by":"crossref","first-page":"e023118","DOI":"10.1136\/bmjopen-2018-023118","article-title":"Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink","volume":"8","author":"Caspard","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaci.2019.12.010_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.inf.0000220229.51531.47","article-title":"A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine","volume":"25","author":"Vesikari","year":"2006","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919317129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919317129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:26:34Z","timestamp":1758792394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919317129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0091674919317129"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.12.010","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}